Myxovirus resistance, osteopontin and suppressor of cytokine signaling 3 polymorphisms predict hepatitis C virus therapy response in an admixed patient population: comparison with IL28B
OBJECTIVES: Suppressor of cytokine signaling 3, myxovirus resistance protein and osteopontin gene polymorphisms may influence the therapeutic response in patients with chronic hepatitis C, and an association with IL28 might increase the power to predict sustained virologic response. Our aims were to...
Main Authors: | Ana Luiza Dias Angelo, Lourianne Nascimento Cavalcante, Kiyoko Abe-Sandes, Taisa Bonfim Machado, Denise Carneiro Lemaire, Fernanda Malta, Joao Renato Pinho, Luiz Guilherme Costa Lyra, Andre Castro Lyra |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2013-10-01
|
Series: | Clinics |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013001001325&lng=en&tlng=en |
Similar Items
-
Blood myxovirus resistance protein‐1 measurement in the diagnostic work‐up of suspected COVID‐19 infection in the emergency department
by: Kirby Tong‐Minh, et al.
Published: (2022-04-01) -
Diagnostic ability of myxovirus resistance-A in pediatric cases of viral-acute respiratory tract infections with vitamin A and zinc deficiencies
by: Dian Kesumapramudya Nurputra, et al.
Published: (2025-03-01) -
Developing a Tool for Differentiation Between Bacterial and Viral Respiratory Infections Using Myxovirus Resistance Protein A and C-Reactive Protein
by: Konstantina Iliopoulou, et al.
Published: (2023-12-01) -
Association of human myxovirus resistance protein A with severity of COVID-19
by: Otto Lehtinen, et al.
Published: (2022-09-01) -
Expression of MxA in esophageal cancer cell lines can influence sensitivity to chemotherapeutic agents but this does not require apoptosis
by: R. M. Hayes, et al.
Published: (2024-09-01)